Relevant articles

Labels: sources manual selection automatic selection

Multiple sclerosis iron rim lesions are linked to impaired cervical spinal cord integrity using the T1/T2-weighted ratio

J Neuroimaging. 2022 Dec 12. doi: 10.1111/jon.13076. Online ahead of print. NO ABSTRACT PMID:36504270 | DOI:10.1111/jon.13076
Continue Reading

PubMed auto

Movement-related beta ERD and ERS abnormalities in neuropsychiatric disorders

Front Neurosci. 2022 Nov 23;16:1045715. doi: 10.3389/fnins.2022.1045715. eCollection 2022. NO ABSTRACT PMID:36507340 | PMC:PMC9726921 | DOI:10.3389/fnins.2022.1045715
Continue Reading

PubMed auto

Transcriptome Profiling in the Hippocampi of Mice with Experimental Autoimmune Encephalomyelitis

Int J Mol Sci. 2022 Nov 27;23(23):14829. doi: 10.3390/ijms232314829. NO ABSTRACT PMID:36499161 | DOI:10.3390/ijms232314829
Continue Reading

PubMed auto

Irrespective of Plaque Activity, Multiple Sclerosis Brain Periplaques Exhibit Alterations of Myelin Genes and a TGF-Beta Signature

Int J Mol Sci. 2022 Nov 30;23(23):14993. doi: 10.3390/ijms232314993. NO ABSTRACT PMID:36499320 | DOI:10.3390/ijms232314993
Continue Reading

PubMed auto

The Multiple Sclerosis Modulatory Potential of Natural Multi-Targeting Antioxidants

Molecules. 2022 Dec 1;27(23):8402. doi: 10.3390/molecules27238402. NO ABSTRACT PMID:36500494 | DOI:10.3390/molecules27238402
Continue Reading

PubMed auto manual

Emerging Potential of the Phosphodiesterase (PDE) Inhibitor Ibudilast for Neurodegenerative Diseases: An Update on Preclinical and Clinical Evidence

Abstract Neurodegenerative diseases constitute a broad range of central nervous system disorders, characterized by neuronal degeneration. Alzheimer’s disease, Parkinson’s disease, amyolotrophic lateral sclerosis (ALS), and …
Continue Reading

PubMed auto manual

Prognostic significance of neurofilament light in Fingolimod therapy for Multiple Sclerosis: A systemic review and meta-analysis based on randomized control trials

Mult Scler Relat Disord. 2022 Nov 17;69:104416. doi: 10.1016/j.msard.2022.104416. Online ahead of print. NO ABSTRACT PMID:36495843 | DOI:10.1016/j.msard.2022.104416
Continue Reading

PubMed auto

Current advances in stem cell therapy in the treatment of multiple sclerosis

Rev Neurosci. 2022 Dec 12. doi: 10.1515/revneuro-2022-0102. Online ahead of print. NO ABSTRACT PMID:36496351 | DOI:10.1515/revneuro-2022-0102
Continue Reading

PubMed manual

Ocrelizumab

Relapsing-remitting and primary progressive multiple sclerosis treated with ocrelizumab: A comparative study

Mult Scler Relat Disord. 2022 Dec 5;69:104441. doi: 10.1016/j.msard.2022.104441. Online ahead of print. NO ABSTRACT PMID:36493559 | DOI:10.1016/j.msard.2022.104441
Continue Reading

PubMed auto

Liposome-based nanoparticles impact on regulatory and effector phenotypes of macrophages and T cells in multiple Sclerosis patients

Biomaterials. 2022 Nov 29;292:121930. doi: 10.1016/j.biomaterials.2022.121930. Online ahead of print. NO ABSTRACT PMID:36493716 | DOI:10.1016/j.biomaterials.2022.121930
Continue Reading

PubMed auto

Articles listed here come from the following sites, with keyword searches for Multiple Sclerosis, autoimmune encephalomyelitis, encephalomyelitis, immune tolerance, myelin.

Design photo created by rawpixel.com - www.freepik.com

This is an independent project that runs on the good will of volunteers

You can help by spreading the word or by donating what you can to pay for the server costs.